GO:0004620 glycerophospholipase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004620 (glycerophospholipase activity) is a molecular function defined as the catalysis of the hydrolysis of a glycerophospholipid.
• This activity is central to membrane phospholipid remodeling, lipid signaling, and energy homeostasis.
• Enzymes with glycerophospholipase activity include phospholipases A1, A2, B, C, and D, as well as lipases such as PNPLA2 (ATGL) and PNPLA3.
• Dysregulation of glycerophospholipase activity is linked to metabolic disorders, cancer, and neurodegeneration.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of these enzymes.
• High-throughput screening and bioinformatics can identify novel regulators and substrates of glycerophospholipase activity.
Description
Glycerophospholipase activity (GO:0004620) is a molecular function that catalyzes the hydrolysis of glycerophospholipids, a fundamental reaction in lipid metabolism and membrane biology. This activity is essential for maintaining membrane integrity, generating lipid second messengers, and providing fatty acids for energy production and signaling. Researchers study this term to understand how cells remodel membranes, respond to metabolic stress, and regulate processes such as inflammation, cell proliferation, and apoptosis. The importance of glycerophospholipase activity extends to human health, as its dysregulation is implicated in obesity, insulin resistance, cancer, and neurodegenerative diseases. By leveraging CRISPR-based gene editing, scientists can now precisely manipulate genes encoding glycerophospholipases to uncover their physiological and pathological roles.
glycerophospholipase activity At A Glance
| GO ID | GO:0004620 |
|---|---|
| GO term | glycerophospholipase activity |
| Ontology | molecular_function |
| Synonym | glycerophospholipid hydrolase activity; phospholipase activity |
| Definition | Catalysis of the hydrolysis of a glycerophospholipid. |
| Major function | Hydrolysis of glycerophospholipids to release fatty acids and lysophospholipids. |
| Related enzymes | Phospholipases A1, A2, B, C, D; PNPLA family lipases. |
| Cellular location | Membranes, cytosol, lysosomes, and extracellular space. |
| Biological processes | Membrane remodeling, lipid signaling, energy homeostasis. |
What Is GO:0004620?
According to the Gene Ontology, GO:0004620 (glycerophospholipase activity) is defined as the catalysis of the hydrolysis of a glycerophospholipid. This activity encompasses enzymes that cleave ester bonds in glycerophospholipids, releasing free fatty acids and lysophospholipids or other products. It is synonymous with glycerophospholipid hydrolase activity and phospholipase activity.
Why Is glycerophospholipase activity Important in Cell Biology?
Glycerophospholipase activity is crucial for cellular lipid homeostasis and signaling. It regulates the release of arachidonic acid and other polyunsaturated fatty acids, which are precursors to eicosanoids that modulate inflammation and immunity. Additionally, this activity is required for the catabolism of stored triglycerides and phospholipids, influencing energy balance and metabolic health. In the brain, glycerophospholipases contribute to synaptic function and neuronal survival, and their dysfunction has been linked to neurodegenerative conditions. Thus, understanding this activity provides insights into fundamental biology and disease mechanisms.
• Regulates membrane phospholipid composition and fluidity.
• Generates lipid second messengers such as arachidonic acid and lysophosphatidic acid.
• Controls energy mobilization from lipid stores.
• Modulates inflammatory responses through eicosanoid production.
• Impacts insulin sensitivity and glucose homeostasis.
• Plays a role in cancer cell proliferation and survival.
• Contributes to neuronal membrane remodeling and synaptic plasticity.
• Involved in lysosomal lipid degradation and autophagy.
• Target for drug development in metabolic and inflammatory diseases.
• Provides biomarkers for disease diagnosis and progression.
What Happens During glycerophospholipase activity?
Substrate Recognition and Binding
In simple terms: The enzyme finds and grabs a glycerophospholipid molecule.
Glycerophospholipases recognize specific glycerophospholipid substrates within membranes or lipid droplets. This binding often involves hydrophobic channels or interfacial activation, allowing the enzyme to access the substrate in a lipid bilayer. The specificity for the sn-1 or sn-2 position determines whether the enzyme acts as a phospholipase A1 or A2.
Catalytic Hydrolysis
In simple terms: The enzyme cuts the glycerophospholipid into smaller pieces.
The catalytic mechanism typically involves a serine hydrolase triad (Ser-His-Asp) or a metal ion cofactor that activates a water molecule for nucleophilic attack on the ester bond. This hydrolysis releases a free fatty acid and a lysophospholipid, or in the case of phospholipase C/D, diacylglycerol or phosphatidic acid.
Product Release and Signaling
In simple terms: The products are released and can send signals or be used for energy.
The released fatty acids, such as arachidonic acid, can be further metabolized into eicosanoids, while lysophospholipids can act as signaling molecules or be reacylated. These products influence diverse cellular processes including inflammation, proliferation, and apoptosis.
Membrane Remodeling and Homeostasis
In simple terms: The enzyme helps keep the cell membrane in good shape.
By removing and replacing fatty acids, glycerophospholipases contribute to the Lands cycle of phospholipid remodeling, maintaining membrane asymmetry and fluidity. This is critical for vesicle trafficking, cell division, and stress responses.
Key Genes Involved in GO:0004620 glycerophospholipase activity
The following genes encode enzymes with glycerophospholipase activity or related functions, and are commonly studied in this context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PNPLA2 | Adipose triglyceride lipase (ATGL) with phospholipase A2 activity | Key regulator of lipolysis and energy homeostasis |
| PNPLA3 | Lipid droplet-associated phospholipase | Associated with nonalcoholic fatty liver disease |
| PLA2G4A | Cytosolic phospholipase A2 | Mediates arachidonic acid release and inflammation |
| PLA2G6 | Calcium-independent phospholipase A2 | Linked to neurodegeneration with brain iron accumulation |
| LPL | Lipoprotein lipase with phospholipase activity | Regulates plasma lipid metabolism |
| LIPE | Hormone-sensitive lipase | Catalyzes diacylglycerol and cholesteryl ester hydrolysis |
| PLD1 | Phospholipase D1 | Generates phosphatidic acid for signaling |
| PLD2 | Phospholipase D2 | Regulates membrane trafficking and cell proliferation |
| PLCB1 | Phospholipase C beta 1 | Produces IP3 and DAG in GPCR signaling |
| PLCG1 | Phospholipase C gamma 1 | Mediates RTK signaling and calcium release |
| PLA2G7 | Lipoprotein-associated phospholipase A2 | Biomarker for cardiovascular risk |
| PLAAT3 | Phospholipase A and acyltransferase 3 | Involved in lipid droplet formation |
| ABHD5 | Alpha/beta hydrolase domain-containing protein 5 | Coactivator of ATGL |
| MGLL | Monoglyceride lipase | Completes lipolysis of triglycerides |
| DGAT1 | Diacylglycerol O-acyltransferase 1 | Opposes glycerophospholipase activity in lipid storage |
| CEPT1 | Choline/ethanolamine phosphotransferase 1 | Synthesizes glycerophospholipids |
| PLA2G2A | Secretory phospholipase A2 group IIA | Antimicrobial and inflammatory roles |
How Is glycerophospholipase activity Regulated?
Glycerophospholipase activity is regulated at multiple levels. Transcriptional control via nuclear receptors such as PPARs and SREBPs modulates enzyme expression in response to metabolic cues. Post-translational modifications, including phosphorylation by AMPK and PKA, can activate or inhibit enzyme activity. Allosteric regulation by lipids and calcium ions also plays a role, particularly for cytosolic phospholipases. Additionally, subcellular localization and interaction with accessory proteins like ABHD5 and CGI-58 control access to substrates.
glycerophospholipase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PNPLA3 | Nonalcoholic fatty liver disease | Knock-in mouse with I148M mutation |
| PLA2G6 | Neurodegeneration with brain iron accumulation | Knockout mouse or patient iPSC-derived neurons |
| PLA2G4A | Inflammatory diseases | Knockout mouse and overexpression cell lines |
| PNPLA2 | Neutral lipid storage disease | Knockout mouse and patient fibroblasts |
| PLD1 | Cancer progression | Xenograft models with knockdown |
Metabolic Disorders
Dysregulated glycerophospholipase activity contributes to obesity, insulin resistance, and nonalcoholic fatty liver disease. For example, mutations in PNPLA3 are strongly associated with hepatic steatosis, and altered ATGL (PNPLA2) function affects lipolysis and energy balance. Targeting these enzymes may offer therapeutic strategies for metabolic syndrome.
Cancer
Elevated phospholipase A2 and D activities are observed in various cancers, promoting cell proliferation, survival, and angiogenesis through lipid second messengers. Inhibition of these enzymes reduces tumor growth in preclinical models. Thus, glycerophospholipases are potential anticancer targets.
Neurodegeneration
Mutations in PLA2G6 cause neurodegeneration with brain iron accumulation, and altered phospholipase activity is implicated in Alzheimer's and Parkinson's diseases. Lipid peroxidation and membrane remodeling defects contribute to neuronal death. Studying glycerophospholipase activity in neurons may reveal new therapeutic avenues.
From glycerophospholipase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PNPLA2 affect lipolysis? | PNPLA2 knockout mouse or CRISPR KO cell line |
| Does the PNPLA3 I148M variant alter lipid droplet dynamics? | Knock-in mouse or isogenic cell line |
| Can overexpression of PLA2G4A enhance inflammation? | Overexpression cell line and mouse models |
| What is the subcellular localization of PLD1? | Tagged knock-in with fluorescent protein |
| Does a point mutation in the catalytic site abolish activity? | CRISPR point mutation knock-in |
| Which genes regulate glycerophospholipase activity? | CRISPR library screening |
How to Study the glycerophospholipase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Glycerophospholipid and fatty acid profiles | Quantify changes in lipid species upon enzyme manipulation |
| Fluorescent activity assay | Enzymatic hydrolysis rate | Screen inhibitors or measure kinetics |
| CRISPR knockout screen | Gene essentiality or modifier of lipid phenotype | Identify novel regulators of glycerophospholipase activity |
| RNA-seq | Transcriptional changes | Assess expression of lipid metabolism genes |
| Proteomics | Protein interactions and modifications | Discover regulatory complexes |
| Live-cell imaging | Subcellular localization and dynamics | Track enzyme recruitment to membranes |
| Western blot | Protein expression and phosphorylation | Validate knockout or overexpression |
| qPCR | mRNA levels | Confirm gene editing efficiency |
Lipidomics and Mass Spectrometry
Mass spectrometry-based lipidomics allows comprehensive profiling of glycerophospholipid species and their hydrolysis products, providing direct readouts of enzyme activity in cells and tissues.
Activity Assays
In vitro assays using fluorescent or radiolabeled substrates measure glycerophospholipase activity in cell lysates or purified enzyme preparations. These assays are essential for kinetic characterization and inhibitor screening.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate glycerophospholipase activity or related phenotypes, such as lipid droplet accumulation or drug resistance.
Imaging and Reporter Systems
Fluorescent reporters for lipid droplets, lysosomes, or specific phospholipids enable live-cell imaging of glycerophospholipase function and localization. FRET-based sensors can detect real-time activity changes.
How CRISPR Can Be Used to Study GO:0004620 glycerophospholipase activity
Knockout
CRISPR knockout of genes encoding glycerophospholipases (e.g., PNPLA2, PLA2G4A) creates loss-of-function models to study their roles in lipid metabolism, signaling, and disease. These models are valuable for validating drug targets and understanding compensatory mechanisms.
Point Mutation
Introducing specific point mutations (e.g., catalytic serine to alanine) via CRISPR base editing or HDR allows precise dissection of enzymatic activity versus non-enzymatic functions. This is critical for distinguishing hydrolysis-dependent phenotypes.
Knock-in
Knock-in of disease-associated variants (e.g., PNPLA3 I148M) or epitope tags enables physiological studies of mutant enzymes in isogenic cell lines or animal models. These models help elucidate genotype-phenotype relationships.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of glycerophospholipases can amplify signaling pathways and reveal gain-of-function effects, such as enhanced lipid droplet turnover or inflammation.
How EDITGENE Supports glycerophospholipase activity Research
Researchers studying glycerophospholipase activity-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism, signaling, or disease. EDITGENE provides comprehensive CRISPR gene editing services to create precisely tailored cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for glycerophospholipase activity research.
Frequently Asked Questions About glycerophospholipase activity
What is glycerophospholipase activity?
Glycerophospholipase activity (GO:0004620) is the catalysis of the hydrolysis of a glycerophospholipid, a key reaction in lipid metabolism.
What genes are involved in glycerophospholipase activity?
Genes such as PNPLA2, PNPLA3, PLA2G4A, PLA2G6, PLD1, and PLCB1 encode enzymes with glycerophospholipase activity.
What diseases are associated with glycerophospholipase activity?
Dysregulation is linked to metabolic disorders, cancer, and neurodegeneration.
How can I study glycerophospholipase activity in the lab?
Common methods include lipidomics, activity assays, CRISPR screens, and imaging.
What is the difference between phospholipase A1, A2, C, and D?
They hydrolyze different bonds in glycerophospholipids, producing distinct products.
Can CRISPR be used to study glycerophospholipase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools.
What is the role of PNPLA2 in lipid metabolism?
PNPLA2 (ATGL) catalyzes the first step of triglyceride hydrolysis and has phospholipase A2 activity.
How is glycerophospholipase activity regulated?
It is regulated transcriptionally, post-translationally, and allosterically by lipids and calcium.
What are the products of glycerophospholipase activity?
Products include free fatty acids, lysophospholipids, diacylglycerol, or phosphatidic acid, depending on the enzyme.
Why is glycerophospholipase activity important for cancer?
It generates lipid second messengers that promote proliferation and survival, making it a therapeutic target.
Conclusion
Glycerophospholipase activity (GO:0004620) is a fundamental molecular function that governs lipid remodeling, signaling, and energy homeostasis. Its dysregulation contributes to major human diseases, including metabolic disorders, cancer, and neurodegeneration. Advanced CRISPR-based models and multi-omics approaches are essential to unravel its complex roles and to develop targeted therapies. EDITGENE offers a comprehensive suite of services to support research on glycerophospholipase activity, from knockout to library screening.
References
- 1. Rahmati M et al.. 2024. Physical activity and prevention of mental health complications: An umbrella review.. Neurosci Biobehav Rev 160:105641 PMID: 38527637
- 2. Bourne MN et al.. 2017. Impact of exercise selection on hamstring muscle activation.. Br J Sports Med 51(13):1021-1028 PMID: 27467123
- 3. Spaulding HR et al.. 2022. AMPK and the Adaptation to Exercise.. Annu Rev Physiol 84:209-227 PMID: 35143330
- 4. Boström P et al.. 2012. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.. Nature 481(7382):463-8 PMID: 22237023
- 5. Park JS et al.. 2021. Chin tuck against resistance exercise for dysphagia rehabilitation: A systematic review.. J Oral Rehabil 48(8):968-977 PMID: 33973284
- 6. Yang Y et al.. 2025. The impact of physical activity on inhibitory control of adult ADHD: a systematic review and meta-analysis.. J Glob Health 15:04025 PMID: 40084538
- 7. Folgueira C et al.. 2024. Remodeling p38 signaling in muscle controls locomotor activity via IL-15.. Sci Adv 10(33):eadn5993 PMID: 39141732
